The synergistic effect of circRNA methylation promotes pulmonary fibrosis

Sha Wang,Wei Luo,Jie Huang,Menglin Chen,Jiawei Ding,Yusi Cheng,Wei Zhang,Shencun Fang,Jing Wang,Jie Chao
DOI: https://doi.org/10.1101/2021.08.05.455186
2021-08-06
Abstract:Abstract Rationale N6-Methyladenosine (m 6 A) is the most common type of RNA methylation modification, mainly occurring on mRNA. Whether m 6 A-modified circRNAs are involved in different settings of pulmonary fibrosis remains unclear. Methods and Results Using an m 6 A-circRNA epitranscriptomic chip, candidate circRNAs were selected, in which hsa_circ_0000672 and hsa_circ_0005654 were specifically involved in SiO 2 -induced pulmonary fibrosis by targeting the same protein, eIF4A3, indicating that the m 6 A modification of these two circRNAs has a synergistic effect on fibroblast dysfunction induced by SiO 2 . A mechanistic study revealed that the m 6 A modification of circRNAs was mainly mediated by the methyltransferase METTL3. Furthermore, METTL3 promoted the activation, migration and activity of pulmonary fibroblasts and participated in SiO 2 -induced pulmonary fibrosis via circRNA m 6 A modification. Conclusion m 6 A methylation of circRNAs mediates silica-induced fibrosis via synergistic effects, enriching the understanding of circRNAs and uncovering a potential new target to treat fibrosis-related diseases.
What problem does this paper attempt to address?